Penn engineers refined a Nile Red staining method to make microplastics visible in creek and tap samples and aim to roll out school-friendly kits as federal funding ramps up.

NYC‑based Runway hit No. 45 on CNBC's Disruptor 50 after a $315M Series E and major product and compute moves that pushed its valuation toward $5.3B.

Morgan State landed $8.9M to build a molecular biology lab and expand microelectronics equipment, a direct boost to the university’s research and training capacity.

CompTIA sees a slight rebound for Portland's tech workforce in 2026 after two years of decline, with AI and data roles leading hiring.

A May 12 federal complaint says Hisense and VIDAA snapshot screens every half‑second, build cross‑device profiles and share them with ad‑tech and Chinese affiliates.

Atara and partner Pierre Fabre won narrow FDA guidance that could allow a resubmission for tabelecleucel; the stock spiked and the companies plan more data and follow‑up.

Philadelphia robotics firm Exyn went public in a $19.4M Nasdaq listing, a rare local tech IPO — even as SEC filings show a $75.9M accumulated deficit and limited cash.

Gradiant closed a Series E that values the Boston water-tech firm at about $2B and said it aims for an IPO in roughly 18 months as it scales into AI and semiconductor markets.

Top AI researchers say limited access to TPUs and server time at Google pushed them to found startups that can buy or control compute. The shift is reshaping Bay Area AI.

Compass Minerals and EnergyX signed an MOU to test direct lithium extraction at the Great Salt Lake, bringing roughly $400M in planned investment and reviving a shelved project.

OpenAI quietly acquired voice‑cloning startup Weights.gg, took its Replay app offline and removed a public catalog of celebrity and political voice models. The tiny team has been folded into OpenAI’s voice work.

Pittsburgh's Krystal Biotech won MHRA approval for VYJUVEK, a topical gene therapy for DEB. The company says U.K. launch timing will depend on reimbursement and payer decisions.

A massive new Nusano plant in West Valley City aims to produce 40+ radioisotopes for diagnostics and cancer therapies while adding high‑tech jobs to Utah. Reservations and supply deals are already underway.